| Medical and health industry has closely relation with our daily life,and a veryimportant impact on the stability and development of China ’s economy and society.Meanwhile, the pharmaceutical industry is a technology-intensive andcapital-intensive industries. At present time, China is in a period of rapiddevelopment,it has a high requirement on the level of development in the medicalfield. As an important component of Medical and health industry,pharmaceuticalcompany has to improve the level of the management, and adjust their owndevelopment mechanism to promote technological level and production level ofinnovation, and gradually increase the development of large-scale pharmaceuticalenterprises, improve the market share of China’s pharmaceutical enterprises toimprove product quality in order to meet the people’s growing medical and healthneeds. M Pharmaceutical Co., Ltd. is an integrated pharmaceutical enterprises, setpharmaceutical production, wholesale and retail and integration. In the early stage,with the rapid development of China’s economic development, and to achieve alarge-scale development in the pharmaceutical industry has a certain influence. Then,with the gradual increase in the number of pharmaceutical companies, competitorsincreased their strength, M pharmaceutical company’s market position was seriouslychallenged. In the external environment and the internal system has been changingcircumstances, require a careful analysis of M pharmaceutical company’smanagement profound changes in the internal and external environment, to developeffective coping mechanisms in the face of fierce market competition, maintainingtheir own advantages and expand market share. In the new market conditions continue to maintain their own development.The paper is the research on the current operating conditions and strategicsystem of the M pharmaceutical company. It selected the proper strategy for Mpharmaceutical company as the consideration of the actual situation. Firstly, thepaper adjusted the theory of related strategic management and related analyticaltools, and put forward the basic methods and logical path. Then analyzed thepharmaceutical company is currently facing M external environment and internalenvironment. On this basis, propose M pharmaceutical companies to differentiatethe content of strategy implementation. External environment for enterprisedevelopment has a very important influence, M pharmaceutical companies faceexternal environment has undergone profound changes, the M pharmaceuticalcompany’s development strategy for reconstruction must grasp the externalenvironment. In this paper, PEST analysis method, the M macro environment facedby pharmaceutical companies were analyzed, followed by the M industryenvironment in which pharmaceutical companies were analyzed, a comparativestudy of its competitors, and identify the strengths and pharmaceutical companies Mweaknesses, opportunities and threats. Pharmaceutical companies in the M internalanalysis, focuses on the pharmaceutical company’s internal M management structure,the current state of talent, enterprise management efficiency, enterprises currentlymarketing methods and channels. The company’s in-house research to understandingthe company’s resources, thereby making appropriate strategic programs. For thespecific situation of Company M pharmaceutical companies for the development ofdifferentiation strategy is the focus of this article, this article M pharmaceuticalcompany carried out the overall situation awareness, on specific strategic programsand methods for selection and assessment, proposed a differentiated strategy is Mpharmaceutical companies to promote their own development of an effective strategy.The implementation of the strategy and the safeguard measures were analyzed and discussed. Implementation of the strategy through differentiated pharmaceuticalcompanies realize M in the new conditions to maintain sustainable development. |
PDF Full Text Request